Syneos Health (SYENS) | Stock Overview & Key Data
Syneos Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €109.90 on December 11, 2023
Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Syneos Health
SYENS
|
5.71B Large-cap | 6.05% | 7.23% | 51.55% | -3.98% | -3.46% | -0.90% | -29.74% | -29.74% | -29.74% | -29.74% | -29.74% |
|
Solvay SA
SOLB
|
2.89B Large-cap | 5.02% | 3.74% | 3.42% | 1.04% | -0.51% | -9.40% | -74.08% | -74.94% | -69.29% | -67.66% | -67.66% |
|
Solvac S.A
SOLV
|
1.53B Large-cap | 0.00% | 6.25% | 17.33% | -5.56% | -7.38% | -13.04% | -33.33% | -37.70% | -18.24% | -17.68% | -17.68% |
|
Titan Cement
TITC
|
3.46B Large-cap | 9.22% | 12.73% | 21.41% | 14.38% | 0.00% | 32.23% | 205.39% | 208.65% | 178.61% | 178.61% | 178.61% |
|
Azelis Group NV
AZE
|
2.52B Large-cap | 1.17% | -3.18% | 40.68% | 10.94% | 10.71% | -22.45% | -52.85% | -62.75% | -62.75% | -62.75% | -62.75% |
|
Tessenderlo Group NV
TESB
|
1.26B Large-cap | 2.25% | -4.88% | -19.33% | -19.49% | -21.95% | -21.73% | -32.50% | -40.93% | -30.83% | -7.92% | -7.92% |
Ownership & Short Interest
Calculate Your Syneos Health Investment Returns
Long-Term Investment Performance Analysis
Syneos Health stock price in Dec 2023 was €94.50, A €1,000.00 lump sum investment in Syneos Health made 2 years ago would be worth approximately €714.29 today, representing a negative return of -28.57%. This translates to an annualized return (CAGR) of -12.54%.
2 Years 6 Months Investment Scenario (Dec 2023 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SYENS's 52-week high and low?
- In the last 52 weeks, Syneos Health reached a high of €82.12 (on February 12, 2026) and a low of €41.76 (on March 23, 2026).
- What is the market cap and P/E ratio for SYENS?
- Curious about Syneos Health's size and valuation? Its market capitalization stands at 5.71B. When it comes to valuation, the P/E ratio (trailing twelve months) is 377.86, and the forward P/E (looking ahead) is 13.10.
- Does SYENS pay dividends? If so, what's the yield?
- As for dividends, Syneos Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Syneos Health's main competitors or similar companies to consider before investing?
When looking at Syneos Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Solvay SA
SOLB2.89B Basic Materials Chemicals -9.40% -74.08% Solvac S.A
SOLV1.53B Basic Materials Chemicals -13.04% -33.33% Titan Cement
TITC3.46B Basic Materials Building Materials 32.23% 205.39% Azelis Group NV
AZE2.52B Basic Materials Specialty Chemicals -22.45% -52.85% Tessenderlo Group NV
TESB1.26B Basic Materials Agricultural Inputs -21.73% -32.50% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Syneos Health, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Syneos Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -1.25%, the Debt to Equity ratio from the most recent quarter is 48.61, and its Gross Profit Margin stands at 27.96%.
- What is the recent revenue and earnings growth for SYENS?
- Looking at Syneos Health's growth, its revenue over the trailing twelve months (TTM) was €6B. Compared to the same quarter last year (YoY), quarterly revenue grew by -16.70%, and quarterly earnings saw a YoY growth of -16.73%.
- How much of SYENS stock is held by insiders and institutions?
- Wondering who owns Syneos Health stock? Company insiders (like executives and directors) hold about 31.39% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 35.17%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.